Corpus Intelligence IC Memo — MILBANK AREA HOSPITAL/AVERA HEALTH 2026-04-26 06:41 UTC
IC Memo — MILBANK AREA HOSPITAL/AVERA HEALTH
Investment Committee Memorandum | SD | 25 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MILBANK AREA HOSPITAL/AVERA HEALTH

CCN 431326 | GRANT, SD | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MILBANK AREA HOSPITAL/AVERA HEALTH is a 25-bed rural/critical access in GRANT, SD with $24.0M in net patient revenue and a 13.7% operating margin. The hospital serves a payer mix of 77.0% Medicare, 4.3% Medicaid, and 18.7% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.7% to 21.1% (+736bps).

Net Revenue HCRIS$24.0M
Current EBITDA COMPUTED$3.3M
Operating Margin COMPUTED13.7%
Occupancy HCRIS18.1%
Revenue / Bed COMPUTED$959K
Net-to-Gross HCRIS46.7%
Distress Probability ML59.6%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
42
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of 13.7% places it above the state median. Among 42 size-comparable peers (12-50 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MILBANK AREA HOSPITAL/AVERA HE (Target)SD25$24.0M13.7%
AVERA ST. LUKESSD50$210.6M-7.3%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD50$129.2M-8.7%
AVERA SACRED HEART HOSPITALSD42$123.1M-1.9%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
SIOUXLAND SURGERY CENTERSD38$105.7M40.1%
AVERA ST MARYSSD50$105.0M-10.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$504K+210bp18mo
Cost to Collect4.5%2.5%$480K+200bp12mo
Denial Rate Reduction12.0%6.5%$475K+198bp12mo
A/R Days Reduction5200.0%3800.0%$292K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$504K
Cost to Collect
$480K
Denial Rate Reduction
$475K
A/R Days Reduction
$292K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.8M
Current EBITDA$3.3M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$5.1M
Current Margin13.7%
Pro Forma Margin21.1%
WC Released (1x)$920K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.1M$39.3M7.78x50.7%
Base (11x exit)10.0x11.0x$5.1M$44.9M8.88x54.8%
Bull Case9.0x11.0x$4.6M$52.4M11.51x63.0%
Bull (12x exit)9.0x12.0x$4.6M$58.5M12.85x66.6%
Bear Case11.0x10.0x$5.6M$28.9M5.19x39.0%
Bear (11x exit)11.0x11.0x$5.6M$33.6M6.03x43.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 77.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 18.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 12-50 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-9.2% / P50=-2.5% / P75=8.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.